Product Code: GDME1407CFR
Over the past two decades, there has been increasing interest in Partial knee replacement (PKR) as a means of treating unicompartmental knee osteoarthritis. Indications have expanded while previous contraindications such as age, body mass index, patellofemoral osteoarthritis, and anterior cruciate ligament (ACL) deficiency have been lifted. Technological advancements in implant design, fixation methods, and surgical techniques have led to improved survival rates, better patient-reported outcomes, and reduced complications. Interest is growing in robotic-assisted techniques, which are poised to optimize results and reproducibility. Cementless designs also look promising, although given the anatomy of the knee condyles, this might introduce more risks to the overall procedure.
European Partial knee replacement (PKR)market was estimated at $100+M in 2016 across the 21 markets covered in this report (Austria, Belgium, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Netherlands, Norway, Poland, Portugal, Russia, Spain, Sweden, Switzerland, Turkey, and UK). By the end of the forecast period in 2023, it is estimated that the market will grow approximately at a Compound Annual Growth Rate (CAGR) of 4.4%.The UK represented the largest portion of the market in 2016, holding more than 22% of the regional revenue, and is expected to maintain this dominance through the forecast period. Norway is expected to be the fastest-growing market through 2023, at a CAGR of 12.1%, while the slowest growth will be observed in Germany.
As countries' economy grows, the volume of partial knee replacement procedures is expected to increase further, primarily due to the demographics of an aging population and a trend towards early surgical intervention in younger patients. In the forecast years, launching and marketing a comprehensive large joint portfolio with a clear value proposition will remain critical to companies' success as they jockey for market position. A long-term foothold within the global knee market hinges on how well companies can align themselves with the primary market force buffeting healthcare today: the need to deliver top-notch, cost-effective care.
The incidences of osteoarthritis of the knee and other degenerative knee diseases are increasing simultaneously with the aging population. Partial knee replacement (PKR), or unicondylar knee arthroplasty (UKA), is an alternative to total knee arthroplasty (TKA) used to treat patients whose osteoarthritic condition is isolated to the medial or lateral tibio-femoral compartments. PKR is a less invasive procedure than TKA that replaces only the damaged part of the joint with a prosthesis, resulting in less blood loss and the preservation of healthy ligaments, cartilage, and bone in the knee. The decision to undergo a PKR instead of TKR is based on the disease stage, patient expectations, published results, and surgeon expertise.
Given the heightened competitive pressures and shrinking reimbursement, the average selling price for Partial knee replacement (PKR) implants is expected to decline. However, it is expected that the revenue from increased procedure volume will make up for this loss.
This report focuses on the market outlook for PKR devices in Europe (Austria, Belgium, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Netherlands, Norway, Poland, Portugal, Russia, Spain, Sweden, Switzerland, Turkey, and UK). The analysis identifies the key unmet needs in the PKR market, discusses the major drivers and barriers of adoption, and provides an in-depth understanding of physicians' perceptions and the future outlook for this market by segment and geography.
Key Questions Answered:
- What is the current and future Partial knee replacement (PKR) market outlook in the developed and emerging markets? What trends are affecting the European market?
- Which are the key, high growth markets that Partial knee replacement (PKR) manufacturers should expand into?
- What are the unmet needs with the current generation of Partial knee replacement (PKR) devices? How will emerging technologies fulfill these unmet needs?
- What are the challenges and complications that have hindered widespread adoption?
- With developing the next-generation of devices, what aspects of the technology are device manufacturers focused on optimizing? How will new entrants impact the Partial knee replacement (PKR) market?
- Overview of recent key industry events and analysis of their market impact.
- Annualized total market revenue, procedure trends, and market outlooks by segment and by region through 2023.
- Key topics covered include strategic competitor assessment, market characterization, identification of unmet needs, reimbursement considerations, evaluating market access in each region covered in the report, and implications of the emerging technologies in the market.
- Analysis of the current and future market competition in the global PKR market. Insightful review of industry drivers, barriers, and challenges.
Reasons to buy:
The report will enable you to -
- Develop and design your in-licensing and out-licensing strategies through a review of marketed products and technologies.
- Develop business strategies by understanding the trends shaping and driving the video laparoscopes market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the video laparoscopes market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Track device sales in country-specific video laparoscopes market from 2014-2023.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
Table of Contents
1. About the Authors
- 1.1. Analyst
- 1.1.1. Tobe Madu, MSc, Analyst, Medical Devices
2. Table of Contents
- 2.1. List of Tables
- 2.2. List of Figures
3. Executive Summary
- 3.1. Key Metrics
- 3.2. Market Dynamics
- 3.3. Key Players
- 3.4. Future Outlook
- 3.5. What Do Physicians Think?
- 4.1. Catalyst
- 4.2. Related Reports
- 4.3. Upcoming Related Reports
5. Market Outlook
- 5.1. Procedure Trends
- 5.2. Pricing Trends
- 5.3. Revenue Trends
- 5.4. Company Share Analysis
6. Market Insights
- 6.1. Europe
- 6.1.1. Denmark, Finland, Norway, and Sweden
- 6.1.2. Belgium, France, and Netherlands
- 6.1.3. Germany and Switzerland
- 6.1.4. UK and Ireland
- 6.1.5. Italy, Portugal, and Spain
- 6.1.6. Austria, Czech Republic, Hungary, and Poland
- 6.1.7. Russia, Turkey, and Greece
7. Competitive Assessment
- 7.1. Overview
- 7.1.1. Robotic Technologies
- 7.1.2. Generic Implants to Address Cost Concerns
- 7.1.3. Advanced Materials
- 7.1.4. Emerging Countries
- 7.2. DePuy Synthes
- 7.2.1. Portfolio Assessment
- 7.2.2. Deal Analysis
- 7.2.3. Competitive Positioning
- 7.3. Stryker
- 7.3.1. Portfolio Assessment
- 7.3.2. Deal Analysis
- 7.3.3. Competitive Positioning
- 7.4. Smith & Nephew
- 7.4.1. Portfolio Assessment
- 7.4.2. Deal Analysis
- 7.4.3. Competitive Positioning
- 7.5. Zimmer Biomet
- 7.5.1. Portfolio Assessment
- 7.5.2. Deal Analysis
- 7.5.3. Competitive Positioning
- 7.6. Other Players
- 8.1. Bibliography
- 8.2. Abbreviations
- 8.3. Methodology
- 8.3.1. Overview
- 8.3.2. Coverage
- 8.3.3. Secondary Research
- 8.3.4. Forecasting Methodology
- 8.3.5. Primary Research Summary
- 8.4. About MediPoint
- 8.5. About GlobalData
- 8.6. Contact Us
- 8.7. Disclaimer
List of Tables
- Table 1: PKR Market, Key Metrics, 2016-2023
- Table 2: Europe PKR Procedure Volume Forecast, 2014-2023
- Table 3: Europe PKR Implant Average Selling Price ($) Forecast, 2014-2023
- Table 4: Europe PKR Market Revenue Forecast ($M), 2014-2023
- Table 5: Europe PKR Company Share Analysis, 20161, 2
- Table 6: DePuy Synthes - Key Marketed Products Assessment
- Table 7: DePuy Synthes - Key Clinical Trials
- Table 8: Stryker - Key Marketed Products Assessment
- Table 9: Stryker - Key Clinical Trials
- Table 10: Smith & Nephew - Key Marketed Products Assessment
- Table 11: Zimmer Biomet - Key Marketed Products Assessment
- Table 12: Summary of Other Players in the PKR Market, 2016
List of Figures
- Figure 1: Europe PKR Market Share Comparison by Country, 2016 and 2023